ANAGENEX Trademark

Trademark Overview


On Monday, June 27, 2022, a trademark application was filed for ANAGENEX with the United States Patent and Trademark Office. The USPTO has given the ANAGENEX trademark a serial number of 97478432. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, April 3, 2024. This trademark is owned by Anagenex, Inc.. The ANAGENEX trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences

Providing a website featuring non-downloadable software using artificial intelligence for finding and marketing FDA approved pharmaceuticals to patients; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
anagenex

General Information


Serial Number97478432
Word MarkANAGENEX
Filing DateMonday, June 27, 2022
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, April 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements


Description of MarkThe mark consists of three shaded quadrilaterals creating two diagonal lines, with two smaller quadrilaterals touching corners to the left of a longer quadrilateral, above the literal element "ANAGENEX".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding advertising, marketing and promotional services for the pharmaceutical and medical industry; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences
Goods and ServicesProviding a website featuring non-downloadable software using artificial intelligence for finding and marketing FDA approved pharmaceuticals to patients; Providing medical and scientific research information in the fields of pharmaceuticals and genetics

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, July 15, 2022
Primary Code035
First Use Anywhere DateWednesday, January 8, 2020
First Use In Commerce DateWednesday, January 8, 2020

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 15, 2022
Primary Code042
First Use Anywhere DateWednesday, January 8, 2020
First Use In Commerce DateWednesday, January 8, 2020

Trademark Owner History


Party NameAnagenex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events


Event DateEvent Description
Monday, April 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 11, 2024ASSIGNED TO LIE
Monday, October 23, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, July 26, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 26, 2023FINAL REFUSAL E-MAILED
Wednesday, July 26, 2023FINAL REFUSAL WRITTEN
Tuesday, June 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 11, 2023NON-FINAL ACTION E-MAILED
Tuesday, April 11, 2023NON-FINAL ACTION WRITTEN
Thursday, March 30, 2023ASSIGNED TO EXAMINER
Saturday, July 16, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, July 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 30, 2022NEW APPLICATION ENTERED